Leading brokers name 3 ASX shares to sell today

On Monday I looked at three ASX shares that have been given buy ratings by brokers this week.

Unfortunately, not all shares have been lucky enough to have been given the highly coveted buy rating.

The three shares listed below have all been given sell ratings. Here’s why:

Adelaide Brighton Ltd (ASX: ABC)

According to a note out of UBS, its analysts have retained their sell rating and reduced the price target on this building products company’s shares to $3.90 following the release of its full year results last week. The broker appears concerned that the weak outlook for the housing market is going to weigh on the company’s performance in the near term, especially with management advising of cost pressures in FY 2019 from energy and imports. The Adelaide Brighton share price is currently trading at $4.75.

Metcash Limited (ASX: MTS)

A note out of Citi reveals that its analysts have retained their sell rating and $2.45 price target on the wholesale distributor’s shares following its strategy and trading update. Although the broker has increased its forecasts for FY 2020 onwards in response to the announced initiatives, it has held firm with its sell rating as it fears there are still structural challenges that put it at risk of falling short of the market’s expectations. The Metcash share price last traded at $2.67.

Ramsay Health Care Limited (ASX: RHC)

Analysts at Goldman Sachs have retained their sell rating but lifted the price target on this private hospital operator’s shares slightly to $52.00. According to the note, Goldman was encouraged with its recent half year result and the expansion of its Australian hospitals margin. It believes this is a testament to the progress on operational efficiencies. However, it is concerned that this has heightened renegotiation risk when it renegotiates with its two largest payors within the next six months. Especially at a time when healthcare affordability is likely to be a central issue. In addition to this, the broker believes we are only in the early stages of the shift to outpatient or lower-cost settings for several key indications. Ramsay’s shares are currently changing hands at $63.03.

Those may be the shares to sell, but these are the ones to buy according to this top analyst.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!